Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

114 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Response by Ortega-Paz et al to Letter Regarding Article, "Magnesium-Based Resorbable Scaffold Versus Permanent Metallic Sirolimus-Eluting Stent in Patients With ST-Segment Elevation Myocardial Infarction: The MAGSTEMI Randomized Clinical Trial".
Ortega-Paz L, Brugaletta S, Gómez-Lara J, Sabaté M. Ortega-Paz L, et al. Circulation. 2020 Apr 14;141(15):e748-e749. doi: 10.1161/CIRCULATIONAHA.120.045964. Epub 2020 Apr 13. Circulation. 2020. PMID: 32282250 No abstract available.
TIcaGrEloR and Absorb bioresorbable vascular scaffold implantation for recovery of vascular function after successful chronic total occlusion recanalization (TIGER-BVS trial): Rationale and study design.
Brugaletta S, Gomez-Lara J, Caballero J, Ortega-Paz L, Teruel L, Jimenez Fernandez M, Romaguera R, Alcalde Martinez V, Ñato M, Molina Navarro E, Gomez-Hospital JA, Correa Vilches C, Joyera M, Cequier A, Sabate M. Brugaletta S, et al. Catheter Cardiovasc Interv. 2018 Jan 1;91(1):1-6. doi: 10.1002/ccd.27196. Epub 2017 Jul 14. Catheter Cardiovasc Interv. 2018. PMID: 28707316
Impact of stent overlapping on long-term clinical outcomes in patients with ST-segment elevation myocardial infarction: insights from the five-year follow-up of the EXAMINATION trial.
Ortega-Paz L, Brugaletta S, Giacchi G, Ishida K, Cequier A, Iñiguez A, Serra A, Jiménez-Quevedo P, Mainar V, Campo G, Tespili M, den Heijer P, Valgimigli M, Serruys PW, Sabaté M. Ortega-Paz L, et al. EuroIntervention. 2017 Aug 4;13(5):e557-e563. doi: 10.4244/EIJ-D-16-00512. EuroIntervention. 2017. PMID: 28242584 Free article.
Severe Cardiac Complications of Shabu Use: An Emerging Drug in Europe.
Pujol-López M, Ortega-Paz L, Roqué M, Bosch X. Pujol-López M, et al. Rev Esp Cardiol (Engl Ed). 2017 Nov;70(11):1014-1016. doi: 10.1016/j.rec.2016.12.039. Epub 2017 Jan 27. Rev Esp Cardiol (Engl Ed). 2017. PMID: 28139393 English, Spanish. No abstract available.
Direct actions of dapagliflozin and interactions with LCZ696 and spironolactone on cardiac fibroblasts of patients with heart failure and reduced ejection fraction.
Ortega-Paz L, Cristóbal H, Ortiz-Perez JT, García de Frutos P, Mendieta G, Sandoval E, Rodriguez JJ, Ortega E, García-Álvarez A, Brugaletta S, Sabaté M, Dantas AP. Ortega-Paz L, et al. ESC Heart Fail. 2023 Feb;10(1):453-464. doi: 10.1002/ehf2.14186. Epub 2022 Oct 27. ESC Heart Fail. 2023. PMID: 36303443 Free PMC article.
Comparison of clinical outcomes in STEMI patients treated with primary PCI according to day-time of medical attention and its relationship with circadian pattern.
Rodríguez-Arias JJ, Ortega-Paz L, Brugaletta S, Freixa X, Masotti M, Regueiro A, Ariza A, Carrillo X, Lidon RM, Garcia J, Cardenas M, Rojas SG, Muñoz JF, Zielonka M, Tizon-Marcos H, Sabaté M. Rodríguez-Arias JJ, et al. Int J Cardiol. 2020 Apr 15;305:35-41. doi: 10.1016/j.ijcard.2020.01.041. Epub 2020 Jan 21. Int J Cardiol. 2020. PMID: 32008846
114 results